Percutaneous CT-guided microwave ablation as maintenance after first-line treatment for patients with advanced NSCLC

References

• StewartBWWildCPWorld Cancer Report 2014Lyon, FranceInternational Agency for Research on Cancer2014
   Google Scholar
• Surveillance, Epidemiology, and End Results Program [homepage on the Internet]SEER Cancer Statistics Review 1975–2011Bethesda, MDNational Cancer Institute2014 [updated September 10, 2014]. Available from: http://seer.cancer.gov/csr/1975_2011/Accessed September 27, 2015
   Google Scholar
• EdgeSBByrdDRCarducciMAAJCC Cancer Staging Handbook: From the AJCC Cancer Staging Manual7th edNew YorkSpringer2009
   Google Scholar
• YangPAllenMSAubryMCClinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003Chest2005128145246216002972
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer NetworkNCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer, Version 42014National Comprehensive Cancer Network2014 Available from: http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdfAccessed May 8, 2014
   Google Scholar
• GoffinJLacchettiCEllisPMFirst-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systemic reviewJ Thorac Oncol20105226027420101151
   PubMed Web of Science ®Google Scholar
• ScagliottiGVDe MarinisFRinaldiMPhase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancerJ Clin Oncol200220214285429112409326
   PubMed Web of Science ®Google Scholar
• SchillerJHHarringtonDBelaniCPComparison of four chemotherapy regimens for advanced non-small-cell lung cancerN Engl J Med20023462929811784875
   PubMed Web of Science ®Google Scholar
• SoriaJCMauguenAReckMSystematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancerAnn Oncol2013241203023180113
   PubMed Web of Science ®Google Scholar
• SandlerAGrayRPerryMCPaclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerN Engl J Med2006355242542255017167137
   PubMed Web of Science ®Google Scholar
• MaemondoMInoueAKobayashiKGefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFRN Engl J Med2010362252380238820573926
   PubMed Web of Science ®Google Scholar
• MitsudomiTMoritaSYatabeYGefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trialLancet Oncol201011212112820022809
   PubMed Web of Science ®Google Scholar
• ZhouCWuYLChenGErlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 studyLancet Oncol201112873574221783417
   PubMed Web of Science ®Google Scholar
• JackmanDMMillerVACioffrediLAImpact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trialsClin Cancer Res200915165267527319671843
   PubMed Web of Science ®Google Scholar
• KwakELBangYJCamidgeDRAnaplastic lymphoma kinase inhibition in non-small-cell lung cancerN Engl J Med2010363181693170320979469
   PubMed Web of Science ®Google Scholar
• ShawATKimDWNakagawaKCrizotinib versus chemotherapy in advanced ALK-positive lung cancerN Engl J Med2013368252385239423724913
   PubMed Web of Science ®Google Scholar
• NadlerEYuERaveloASingAForsythMGruschkusSBevacizumab treatment to progression after chemotherapy: outcomes from a U.S. community practice networkOncologist201116448649621441299
   PubMed Web of Science ®Google Scholar
• Paz-AresLde MarinisFDediuMMaintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): a double-blind, phase 3, randomised controlled trialLancet Oncol201213324725522341744
   PubMed Web of Science ®Google Scholar
• Paz-AresLGde MarinisFDediuMPARAMOUNT: Final overall survival results of the phase III study of maintenance pemetrexed versus placebo immediately after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancerJ Clin Oncol201331232895290223835707
   PubMed Web of Science ®Google Scholar
• PérolMChouaidCPérolDRandomized, phase III study of gemcitabine or erlotinib maintenance therapy versus observation, with predefined second-line treatment, after cisplatin-gemcitabine induction chemotherapy in advanced non-small-cell lung cancerJ Clin Oncol201230283516352422949150
   PubMed Web of Science ®Google Scholar
• BrodowiczTKrzakowskiMZwitterMCisplatin and gemcitabine first-line chemotherapy followed by maintenance gemcitabine or best supportive care in advanced non-small cell lung cancer: a phase III trialLung Cancer200652215516316569462
   PubMed Web of Science ®Google Scholar
• CappuzzoFCiuleanuTStelmakhLErlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 studyLancet Oncol201011652152920493771
   PubMed Web of Science ®Google Scholar
• GoldbergSNGrassiCJCardellaJFImage-guided Tumor Ablation: Standardization of terminology and reporting criteriaRadiology2005235372873915845798
   PubMed Web of Science ®Google Scholar
• SofocleousCTMayBPetreENPulmonary thermal ablation in patients with prior pneumonectomyAJR Am J Roentgenol20111965W606W61221512052
   PubMed Web of Science ®Google Scholar
• WolfFJGrandDJMachanJTDipetrilloTAMayo-SmithWWDupuyDEMicrowave ablation of lung malignancies: effectiveness, CT findings, and safety in 50 patientsRadiology2008247387187918372457
   PubMed Web of Science ®Google Scholar
• BelfioreGRonzaFBelfioreMPPatients’ survival in lung malignancies treated by microwave ablation: our experience on 56 patientsEur J Radiol201382117718123099201
   PubMed Web of Science ®Google Scholar
• CarrafielloGManginiMFontanaFMicrowave ablation of lung tumours: single-centre preliminary experienceRadiol Med20141191758224234180
   PubMed Web of Science ®Google Scholar
• KwanSWMortellKETalenfeldADBrunnerMCThermal ablation matches sublobar resection outcomes in older patients with early-stage non–small cell lung cancerJ Vasc Interv Radiol201425119.e124365502
   PubMed Web of Science ®Google Scholar
• DupuyDETreatment of medically inoperable non-small-cell lung cancer with stereotactic body radiation therapy versus image-guided tumor ablation: can interventional radiology compete?J Vasc Interv Radiol20132481139114523796858
   PubMed Web of Science ®Google Scholar
• HowingtonJABlumMGChangACBalekianAAMurthySCTreatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesChest20131435 Supple278Se313S23649443
   PubMed Web of Science ®Google Scholar
• GriecoCASimonCJMayo-SmithWWDiPetrilloTAReadyNEDupuyDEPercutaneous image-guided thermal ablation and radiation therapy: outcomes of combined treatment for 41 patients with inoperable stage I/II non-small-cell lung cancerJ Vasc Interv Radiol20061771117112416868164
   PubMed Web of Science ®Google Scholar
• WeiZYeXYangXMicrowave ablation in combination with chemotherapy for the treatment of advanced non-small cell lung cancerCardiovasc Intervent Radiol201538113514224809754
   PubMed Web of Science ®Google Scholar
• EisenhauerEATherassePBogaertsJNew response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)Eur J Cancer200945222824719097774
   PubMed Web of Science ®Google Scholar
• OngCKLirkPSeymourRAJenkinsBJThe efficacy of preemptive analgesia for acute postoperative pain management: a meta-analysisAnesth Analg2005100375777315728066
   PubMed Web of Science ®Google Scholar
• DurickNALaesekePFBroderickLSMicrowave ablation with triaxial antennas tuned for lung: results in an in vivo porcine modelRadiology20082471808718292471
   PubMed Web of Science ®Google Scholar
• PereiraPLMasalaSCardiovascular and Interventional Radiological Society of Europe (CIRSE)Standards of practice: guidelines for thermal ablation of primary and secondary lung tumorsCardiovasc Intervent Radiol201235224725422271076
   PubMed Web of Science ®Google Scholar
• National Cancer InstituteCommon Terminology Criteria for Adverse Events (CTCAE) v403U.S. Department Of Health And Human Services2010 Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdfAccessed September 27, 2015
   Google Scholar
• YeXFanWMinimally Invasive and Comprehensive Treatment of Lung Cancer Branch, Professional Committee of Minimally Invasive Treatment of Cancer, Chinese Anti-Cancer AssociationExpert consensus for thermal ablation of primary and metastatic lung tumorsZhongguo Fei Ai Za Zhi2014174294301 Chinese24758903
   PubMedGoogle Scholar
• DearingKRSangalAWeissGJMaintaining clarity: Review of maintenance therapy in non-small cell lung cancerWorld J Clin Oncol20145210311324829857
   PubMedGoogle Scholar
• PoloVBesseBMaintenance strategies in stage IV non-small-cell lung cancer (NSCLC): in which patients, with which drugs?Ann Oncol20142571283129324351398
   PubMed Web of Science ®Google Scholar
• LeeHJinGYHanYMComparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapyCardiovasc Intervent Radiol201235234335021626257
   PubMed Web of Science ®Google Scholar
• LiXZhaoMWangJPercutaneous CT-Guided Radiofrequency Ablation as Supplemental Therapy After Systemic Chemotherapy for Selected Advanced Non–Small Cell Lung CancersAJR Am J Roentgenol201320161362136724261378
   PubMed Web of Science ®Google Scholar
• YuHASimaCSHuangJLocal therapy with continued EGFR tyrosine kinase inhibitor therapy as a treatment strategy in EGFR-mutant advanced lung cancers that have developed acquired resistance to EGFR tyrosine kinase inhibitorsJ Thorac Oncol20138334635123407558
   PubMed Web of Science ®Google Scholar
• DupuyDEDiPetrilloTGandhiSRadiofrequency ablation followed by conventional radiotherapy for medically inoperable stage I non-small cell lung cancerChest2006129373874516537876
   PubMed Web of Science ®Google Scholar
• ChanMDDupuyDEMayo-SmithWWNgTDiPetrilloTACombined radiofrequency ablation and high-dose rate brachytherapy for early-stage non-small-cell lung cancerBrachytherapy201110325325920739227
   PubMed Web of Science ®Google Scholar
• LiuHSteinkeKHigh-powered percutaneous microwave ablation of stage I medically inoperable non-small cell lung cancer: a preliminary studyJ Med Imaging Radiat Oncol201357446647423870347
   PubMed Web of Science ®Google Scholar
• LuQCaoWHuangLCT-guided percutaneous microwave ablation of pulmonary malignancies: Results in 69 casesWorld J Surg Oncol2012108022564777
   PubMed Web of Science ®Google Scholar
• VoglTJWorstTSNaguibNNAckermannHGruber-RouhTNour-EldinNEFactors influencing local tumor control in patients with neoplastic pulmonary nodules treated with microwaveablation: a risk-factor analysisAJR Am J Roentgenol2013200366567223436860
   PubMed Web of Science ®Google Scholar
• Hines-PeraltaASukhatmeVReganMSignorettiSLiuZJGoldbergSNImproved tumor destruction with arsenic trioxide and radiofrequency ablation in three animal modelsRadiology20062401828916720872
   PubMed Web of Science ®Google Scholar
• HakiméAHines-PeraltaAPeddiHCombination of radiofrequency ablation with antiangiogenic therapy for tumor ablation efficacy: study in miceRadiology2007244246447017641366
   PubMed Web of Science ®Google Scholar